Sandbox/table

Jump to navigation Jump to search

The following table contains the main risk factors for CDI:[1][2][3][2][2]

Alterations in the coagulation system
Consumption of clotting factors
Increased concentrations of fibrin degradation products
Disseminated intravascular coagulation


Organ/Tissue Effect
Endothelial cells There is no clear evidence of endovascular damage
Liver Causes hepatocellular necrosis which could impair the synthesis of proteins of the coagulation system
Adrenal cortex Affects the synthesis of enzymes responsible for the synthesis of steroids, leading to hypotension, and fluid and electrolytes disturbances.
Lymphatic system [[Necrosis of the spleen, lymph nodes and thymus; Apoptosis of lymphocytes leading to lymphopenia.



table

Countries with a reported prevalence <15% of H. pylori resistance to clarithromycin
Diagnostic test North America South America Middle East Far East
ELISA (serology) detects:
  • Viral Antigen
  • IgM and IgG antibody | hol

There is a reported prevalence of 15% in the Northeast of the US.

  1. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
  2. 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
  3. Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.